既往开放肾下腹主动脉修复失败后行开窗/分支血管腔内主动脉修复与初次开窗/分支血管腔内主动脉修复的结局比较
基于VQI复杂腔内主动脉模块2014至2022年数据,比较既往开放修复后行F/BEVAR(102例)与初次F/BEVAR(3331例)的结局。既往开放修复组完成性内漏更低(25% vs 36%),围手术期死亡率无差异(2% vs 2.9%),1年瘤囊动态和5年死亡率相似。
要点
- 既往开放修复后F/BEVAR完成性内漏更低(25% vs 36%),主要因II型内漏更少(11% vs 20%)。
- 两组围手术期死亡率无差异(2% vs 2.9%,P = .78)。
核心结论
- 基于VQI数据,既往开放修复后行F/BEVAR似乎耐受良好且安全。
- 既往开放修复患者完成性II型内漏率更低,瘤囊动态和5年死亡率与初次F/BEVAR患者相似。
研究设计与样本
- 使用VQI复杂腔内腹主动脉瘤模块2014至2022年数据,识别所有单阶段F/BEVAR修复患者,分为既往开放修复组(102例)和初次F/BEVAR组(3331例)。
- 主要结局为围手术期死亡率和完成性内漏,次要结局为5年生存率和1年瘤囊动态。
- 连续变量采用Wilcoxon秩和检验,分类变量采用χ2分析,5年死亡率采用Kaplan-Meier法和Cox回归分析。
主要发现
- 既往开放修复组外周动脉疾病(22.0% vs 7.4%)、既往吸烟(67% vs 56%)、由中/高容量医师手术(74% vs 62%)比例更高,女性比例更低(8.8% vs 23.0%)(均P < .05)。
- 既往开放修复组动脉瘤累及更近端(中位锚定区7 [IQR 6-8] vs 8 [IQR 7-8])、AAA直径更大(62 mm [IQR 56-66 mm] vs 58 mm [IQR 55-63 mm])、更多使用医师改良内移植物(36% vs 20%)、手术时间更长(240分钟 [IQR 186-308分钟] vs 206分钟 [IQR 155-272分钟])、腹腔干(51% vs 26%)和肠系膜上动脉(86% vs 73%)受累率更高(均P < .05)。
- 既往开放修复组完成性内漏更低(25% vs 36%),II型内漏更低(11% vs 20%),但不确定性内漏更高(11% vs 5.1%)(均P < .01)。
- 围手术期死亡率无差异(2% vs 2.9%;P = .78)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Because aneurysmal disease is progressive, proximal disease progression and para-anastomotic aneurysms are complications experienced after open infrarenal abdominal aortic aneurysm (AAA) repair. As such, fenestrated or branched endovascular repair (F/BEVAR) may be indicated in these patients. Data describing fenestrated endovascular aneurysm repair after prior open surgical repair (OSR) are limited to institutional databases. The aim of our study is to describe the safety and efficacy of fenestrated/branched endovascular aneurysm repair (F/BEVAR) in patients with prior OSR compared with primary F/BEVAR using the Vascular Quality Initiative. METHODS: Using the VQI complex endovascular AAA module from 2014 to 2022, we identified all single-staged F/BEVAR repair in patients having prior OSR or no prior aortic surgery (primary F/BEVAR). The primary outcomes were perioperative mortality and completion endoleaks. Secondary outcomes were 5-year survival and 1-year sac dynamics. Between the two cohorts, differences in the primary and secondary outcomes were evaluated using Wilcoxon rank-sum tests for continuous variables and χ2 analysis for categorical variables. Kaplan-Meier methods and Cox regression were used to examine 5-year mortality. RESULTS: We identified 3331 primary F/BEVAR patients and 102 prior OSR patients. Patients with prior OSR were more likely to have peripheral arterial disease (22.0% vs 7.4%), prior smoking (67% vs 56%), and undergo F/BEVAR with medium-/high-volume physicians (74% vs 62%), but less likely to be female (8.8% vs 23.0%) (all P < .05). Patients with prior OSR were also more likely to have a more proximal aneurysm extent (median zone 7 [interquartile range (IQR), zones 6-8] vs zone 8 [IQR, zones 7-8]), larger AAA diameters (62 mm [IQR, 56-66 mm] vs 58 mm [IQR, 55-63 mm]), receive a physician-modified endograft (PMEG) vs commercial custom-made device (36% vs 20% physician-modified endograft), have longer surgery times (240 minutes [IQR, 186-308 minutes] vs 206 minutes [IQR, 155-272 minutes]), and have a higher rate of celiac artery (51% vs 26%) and superior mesenteric artery (86% v 73%) artery involvement (all P < .05). Patients with prior OSR had lower rates of completion endoleaks (25% vs 36%), driven by lower rates of type II leaks (11% vs 20%) despite higher rates of indeterminate leaks (11% vs 5.1%) (all P < .01). There was, however, no difference in perioperative mortality (2% vs 2.9%; P = .78). They had similar 1-year sac dynamics (48% vs 50% regression; 12% vs 8% expansion; P > .5) and 5-year mortality (23% vs 18%; hazard ratio [HR], 1.44 [IQR, 0.89-2.31]; P = .13). CONCLUSIONS: Based on VQI data, F/BEVAR after prior OSR seems to be well-tolerated and safe. Prior OSR patients also had lower rates of completion type II endoleaks and similar sac dynamics and 5-year mortality compared with primary F/BEVAR patients.
引用
- John ES, Wu WW, Yadavalli SD, et al. Outcomes following fenestrated/branched endovascular aortic repair for failed open infrarenal aortic repair compared with primary fenestrated/branched endovascular aortic repair. J Vasc Surg. 2025. PMID: 39848505. doi:10.1016/j.jvs.2025.01.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。